Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial

Hamid Rezvani(Inserm), Sina Salari(Shahid Beheshti University of Medical Sciences), Abolghasem Allahyari(Mashhad University of Medical Sciences), Seyed Mohammadreza Mortazavizadeh(Islamic Azad University, Yazd), Alireza Sadeghi(Isfahan University of Medical Sciences), Ali Hajiqolami(Isfahan University of Medical Sciences), Babak Shazad(Kermanshah University of Medical Sciences), Moein Karbalaeian(Yazd University), Mehrdad Payandeh(Kermanshah University of Medical Sciences), Amirabbas Nekuee(Isfahan University of Medical Sciences), Adnan Khosravi(Shahid Beheshti University of Medical Sciences), Siroos Qarib(Guilan University of Medical Sciences), Mohammadreza Vahidfar(Yazd University), Shahab Meskinimood(Tehran University of Medical Sciences), Nassim Anjidani, Safa Najafi(Tehran University of Medical Sciences), Alireza Rezvani(Shiraz University of Medical Sciences), Afsaneh Alikhasi(Tehran University of Medical Sciences), Mohsen Rajaeinejad(Aja University of Medical Sciences), Mojtaba Ghadyani(Shahid Beheshti University of Medical Sciences), Mohsen Esfandbod(Tehran University of Medical Sciences)

Clinical Therapeutics

April 22, 2020

Cited by 15

|Journal of Biological Chemistry|2007|88

|American Journal of Tropical Medicine and Hygiene|2007|61

|Journal of Hospital Infection|2008|50

|Journal of Research in Medical Sciences|2019|29

|Journal of Physics D Applied Physics|2020|20

Related Papers